合成路线1
该中间体在本合成路线中的序号:
(I) Synthesis of intermediate 1,4-bis(3,4,5-trimethoxyphenyl)butane-1,4-dione (V). This compound can be obtained by three related methods:
1. The Grignard reaction of 3,4,5-trimethoxybenzaldehyde (I) with vinylmagnesium bromide (II), followed by oxidation with MnO2, gives 1-(3,4,5-trimethoxyphenyl)-2-propen-1-one (III), which is then condensed with aldehyde (I) by means of the thiazolium salt (IV) to yield the target intermediate (V).
2. The condensation of 3,4,5-trimethoxyacetophenone (VI) with methylamine and formaldehyde gives 3-(dimethylamino)-1-(3,4,5-trimethoxyphenyl)-1-propanone (VII), which is treated with methyl iodide at 80 C to afford the previously reported propenone intermediate (III).
3.The direct dimerization of acetophenone (VI) by means of LDA and CuCl2 also gives the target intermediate (V).
Synthesis of the target compound: The reduction of the butanedione intermediate (V) with LiAlH4 or NaBH4 gives (RS,RS)-1,4-bis(3,4,5-trimethoxyphenyl)butane-2,3-diol (IX), which is dehydrated to the target tetrahydrofuran by means of TFA, PdCl2/Cu(NO3)2 or MsCl/pyridine. Alternatively, the reduction of butanedione (V) can be performed stepwise, first with LiAlH(O-tBu)3 to give the intermediate hydroxyketone (VIII), which is reduced to the diol (IX). The isolation of the intermediate hydroxyketone (VIII) allows the separation of enantiomers offering the possibility of obtaining chiral forms of the target tetrahydrofuran.
【1】
Doebber, T.W.; Beattie, T.R.; Shen, T.-Y.; Hwang, S.-B.; Biftu, T. (Merck & Co., Inc.); New 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists. AU 8656430; EP 0199324; ES 8801909; JP 1987000077 .
|
【2】
Biftu, T.; Chabala, J.C.; Acton, J.; Kuo, C.-H.; Stevenson, R.; 2,5-DIARYLTETRAHYDROFURANS: PAF ANTAGONISTS. Drugs Fut 1989, 14, 4, 359.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(II) |
16524 |
bromo(vinyl)magnesium
|
1826-67-1 |
C2H3BrMg |
详情 | 详情
|
(III) |
27941 |
1-(3,4,5-trimethoxyphenyl)-2-propen-1-one
|
|
C12H14O4 |
详情 |
详情
|
(IV) |
44365 |
3,4-diethyl-5-(2-hydroxyethyl)-1,3-thiazol-3-ium bromide
|
|
C9H16BrNOS |
详情 |
详情
|
(V) |
44387 |
1,4-bis(3,4,5-trimethoxyphenyl)-1,4-butanedione
|
|
C22H26O8 |
详情 |
详情
|
(VI) |
44362 |
1-(3,4,5-trimethoxyphenyl)-1-ethanone
|
1136-86-3 |
C11H14O4 |
详情 | 详情
|
(VII) |
44363 |
3-(dimethylamino)-1-(3,4,5-trimethoxyphenyl)-1-propanone
|
|
C14H21NO4 |
详情 |
详情
|
(VIII) |
44388 |
4-hydroxy-1,4-bis(3,4,5-trimethoxyphenyl)-1-butanone
|
|
C22H28O8 |
详情 |
详情
|
(IX) |
44389 |
(1R,4R)-1,4-bis(3,4,5-trimethoxyphenyl)-1,4-butanediol
|
|
C22H30O8 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(IV) A total synthesis of gomisin A has been published:
The asymetric hydrogenation of 2-(carboxymethyl)-3-[3-methoxy-4,5-(methylenedioxy)phenyl]-2(E)-propenoic acid methyl ester (I) gives the (S)-isomer of the saturated hemiester (II), which by reduction with calcium borohydride is converted into the lactone (III). The aldol condensation with 3,4,5-trimethoxybenzaldehyde (IV), followed by dehydration with acetic anhydride, affords the benzylidene-lactone (V). The biphenyl cyclization of (V) with ferric perchlorate in dichloromethane - trifluoroacetic acid yields the dibenzocyclooctene compound (VI) (and its regioisomer). The reduction of (VI) with dibutylaluminum hydride affords diol (VII), which is acetylated with acetic anhydride to the diacetate (VIII). The reaction of (VIII) with ammonium formate and paladium chloride-triphenylphosphine complex and then with NaOH gives the exo-methylene derivative (IX), which is epoxidized with OsO4 - methanesulfonyl chloride and NaH to the epoxide (X). Finally, this compound is deprotected and submitted to ring-opening with LiAlH4.
【1】
Mitsuhashi, H.; Wakamatsu, T.; Mukaiyama, C.; Tanaka, M.; Synthesis and optically pure gomisin A and schizandrin: The first total synthesis of gomisin A and schizandrin having naturally occurring configurations. Tetrahedron Lett 1992, 33, 29, 4165.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11133 |
(E)-4-(7-Methoxy-1,3-benzodioxol-5-yl)-3-(methoxycarbonyl)-3-butenoic acid
|
|
C14H14O7 |
详情 |
详情
|
(II) |
11134 |
(3S)-4-Methoxy-3-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]-4-oxobutyric acid
|
|
C14H16O7 |
详情 |
详情
|
(III) |
11135 |
(4S)-4-[(7-Methoxy-1,3-benzodioxol-5-yl)methyl]dihydro-2(3H)-furanone
|
|
C13H14O5 |
详情 |
详情
|
(IV) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(V) |
11137 |
(4S)-4-[(7-Methoxy-1,3-benzodioxol-5-yl)methyl]-3-[(E)-(3,4,5-trimethoxyphenyl)methylidene]dihydro-2(3H)-furanone
|
|
C23H24O8 |
详情 |
详情
|
(VI) |
11138 |
(14aS)-6,7,8,9-Tetramethoxy-14,14a-dihydrobenzo[3,4]furo[3',4':6,7]cycloocta[1,2-f][1,3]benzodioxol-3(1H)-one
|
|
C23H22O8 |
详情 |
详情
|
(VII) |
11139 |
[(7S)-7-(Hydroxymethyl)-1,2,3,13-tetramethoxy-7,8-dihydrobenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-6-yl]methanol
|
|
C23H26O8 |
详情 |
详情
|
(VIII) |
11140 |
[(7S)-6-[(acetoxy)methyl]-1,2,3,13-tetramethoxy-7,8-dihydrobenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-7-yl]methyl acetate
|
|
C27H30O10 |
详情 |
详情
|
(IX) |
11141 |
[(7S)-1,2,3,13-Tetramethoxy-6-methylene-5,6,7,8-tetrahydrobenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-7-yl]methanol
|
|
C23H26O7 |
详情 |
详情
|
(X) |
11142 |
Methanesulfonic acid (6S,7R)-1,2,3,13-tetramethoxy-5,6,7,8-tetrahydrospiro[benzo[3,4]cycloocta[1,2-f][1,3]benzodioxole-6,2'-oxiran]-7-ylmethyl ester; Methanesulfonic acid (6S,7R)-1,2,3,13-tetramethoxy-5,6,7,8-tetrahydrospiro[benzo[3,4]cycloocta[1,2-f][1,3]benzodioxole-6,2'-oxiran]-7-yl methyl ester |
|
C24H28O10S |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(VII) The O-silyl stilbene precursor (IV) was also synthesized by the Wittig reaction either between 3,4,5-trimethoxybenzaldehyde (VII) and the phosphonium salt (VIII) or between phosphonium bromide (IX) and 3-(tert-butyldimethylsilyloxy)-4-methoxybenzaldehyde (X), to furnish in both cases a mixture of the target Z-stilbene (IV) and its E-isomer (XI), which were separated by flash chromatography
【1】
Pettit, G.R.; Singh, S.B.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Schmidt, J.M.; Hogan, F.; Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6. J Med Chem 1995, 38, 10, 1666.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
26118 |
tert-butyl[2-methoxy-5-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenoxy]dimethylsilane; tert-butyl(dimethyl)silyl 2-methoxy-5-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl ether
|
|
C24H34O5Si |
详情 |
详情
|
(VII) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(VIII) |
26117 |
(3-[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzyl)(triphenyl)phosphonium bromide
|
|
C32H38BrO2PSi |
详情 |
详情
|
(IX) |
19866 |
triphenyl(3,4,5-trimethoxybenzyl)phosphonium bromide
|
|
C28H28BrO3P |
详情 |
详情
|
(X) |
26114 |
3-[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzaldehyde
|
|
C14H22O3Si |
详情 |
详情
|
(XI) |
60508 |
tert-butyl{2-methoxy-4-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenoxy}dimethylsilane; tert-butyl(dimethyl)silyl 2-methoxy-4-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl ether
|
|
C24H34O5Si |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(VIII) Heating p-fluorobenzaldehyde (I) with propionic anhydride (II) in the presence of sodium propionate affords methyl cinnamic acid derivative (III), which is then hydrogenated over Pd/C in EtOH to provide methyl hydrocinnamic acid derivative (IV). Ring closure of (IV) is then performed by heating with polyphosphoric acid to yield methylindanone derivative (V). Condensation of (V) with cyanoacetic acid (VI) by means of ammonium acetate and HOAc in refluxing toluene, followed by treatment with KOH in refluxing EtOH, provides acetic acid derivative (VII), which is then condensed with 3,4,5-trimethoxybenzaldehyde (VIII) by heating with NaOMe in MeOH to give substituted benzylidene derivative (IX). The target product can be finally obtained either by direct condensation of (IX) with benzylamine (XI) by means of DMAP and EDC in DMA or by first conversion of (IX) into the corresponding acetyl chloride by reaction with oxalyl chloride in refluxing THF, followed by coupling with benzylamine (XI) in CH2Cl2.
Alternatively, the desired compound can also be obtained by coupling of acetic acid derivative (VII) with benzylamine (XI) by means of DMAP, EDC in DMA to afford N-benzyl acetamide derivative (XII), followed by condensation with 3,4,5-trimethoxybenzaldehyde (VIII) by heating with NaOMe in MeOH.
【1】
Sperl, G.; Gross, P.; Brendel, K.; Pamucku, R.; Piazza, G.A. (University of Arizona); Substd. benzylidene indenyl formamides, acetamides and propionamides. WO 9747303 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12337 |
4-fluorobenzaldehyde |
459-57-4 |
C7H5FO |
详情 | 详情
|
(II) |
20095 |
propionic anhydride
|
123-62-6 |
C6H10O3 |
详情 | 详情
|
(III) |
48870 |
(Z)-3-(4-fluorophenyl)-2-methyl-2-propenoic acid
|
|
C10H9FO2 |
详情 |
详情
|
(IV) |
48871 |
3-(4-fluorophenyl)-2-methylpropionic acid
|
|
C10H11FO2 |
详情 |
详情
|
(V) |
48872 |
6-Fluoro-2-methylindanone
|
|
C10H9FO |
详情 |
详情
|
(VI) |
48873 |
2-Oxopropionitrile; Acetylcyanide; Pyruvonitrile
|
|
C3H3NO |
详情 |
详情
|
(VII) |
48874 |
2-(5-fluoro-2-methyl-1H-inden-3-yl)acetic acid
|
|
C12H11FO2 |
详情 |
详情
|
(VIII) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(IX) |
48875 |
2-[5-fluoro-2-methyl-1-[(E)-(3,4,5-trimethoxyphenyl)methylidene]-1H-inden-3-yl]acetic acid
|
|
C22H21FO5 |
详情 |
详情
|
(X) |
48876 |
2-[5-fluoro-2-methyl-1-[(E)-(3,4,5-trimethoxyphenyl)methylidene]-1H-inden-3-yl]acetyl chloride
|
|
C22H20ClFO4 |
详情 |
详情
|
(XI) |
15147 |
Benzylamine; Phenylmethanamine
|
100-46-9 |
C7H9N |
详情 | 详情
|
(XII) |
48877 |
N-benzyl-2-(5-fluoro-2-methyl-1H-inden-3-yl)acetamide
|
|
C19H18FNO |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(IX) Protection of 3,4,5-trimethoxybenzaldehyde (IX) with ethylene glycol (X) affords acetal (XI). After lithiation of (XI) by means of butyllithium, addition to veratraldehyde (XII) furnishes carbinol (XIII). Finally, cyclization of hydroxy acetal (XIII) with alkyne (VIII) under acidic conditions provides the title naphthol derivative.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
57432 |
methyl 6-ethyl-4-oxo-2-octynoate
|
|
C11H16O3 |
详情 |
详情
|
(IX) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(X) |
11295 |
Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol |
107-21-1 |
C2H6O2 |
详情 | 详情
|
(XI) |
57434 |
2-(3,4,5-trimethoxyphenyl)-1,3-dioxolane; 4-(1,3-dioxolan-2-yl)-2,6-dimethoxyphenyl methyl ether
|
|
C12H16O5 |
详情 |
详情
|
(XII) |
18304 |
3,4-Dimethoxybenzaldehyde; Veratraldehyde
|
120-14-9 |
C9H10O3 |
详情 | 详情
|
(XIII) |
57435 |
(3,4-dimethoxyphenyl)[6-(1,3-dioxolan-2-yl)-2,3,4-trimethoxyphenyl]methanol
|
|
C21H26O8 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) Addition of ethylmagnesium bromide to 3,4,5-trimethoxybenzaldehyde (I) gave secondary alcohol (II), which was converted into ketone (III) by Swern oxidation with DMSO and oxalyl chloride. Piperidinium acetate-catalyzed aldol condensation of propiophenone (III) with 3-hydroxy-4-methoxybenzaldehyde (IV), with water removal over 4 Å molecular sieves, gave the corresponding chalcone, obtained as a mixture of geometric isomers, from which the major E-isomer was separated by column chromatography.
【1】
Ducki, S.; Forrest, R.; Hadfield, J.A.; Kendall, A.; Lawrence, N.J.; McGown, A.T.; Rennison, D.; Potent antimitotic and cell growth inhibitory properties of substituted chalcones. Bioorg Med Chem Lett 1998, 8, 9, 1051.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(II) |
18453 |
1-(3,4,5-trimethoxyphenyl)-1-propanol
|
|
C12H18O4 |
详情 |
详情
|
(III) |
18454 |
1-(3,4,5-trimethoxyphenyl)-1-propanone
|
|
C12H16O4 |
详情 |
详情
|
(IV) |
18455 |
3-hydroxy-4-methoxybenzaldehyde; Isovanillin
|
621-59-0 |
C8H8O3 |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(I) Reduction of 3,4,5-trimethoxybenzaldehyde (I) with NaBH4 provided benzyl alcohol (II). After conversion of (II) to the benzyl chloride (III) using SOCl2, its reaction with PPh3 (IV) in refluxing xylene afforded phosphonium salt (V). Subsequent Wittig reaction of the corresponding ylide with 4,4-(ethylenedioxy)cyclohexanone (VI) produced the benzylidene derivative (VII), which was reduced to benzyl compound (VIII) by catalytic hydrogenation over Pd/C. The ketal protecting group of (VIII) was then removed by acid hydrolysis to yield cyclohexanone (IX). Finally, the target tetrahydroquinazoline was obtained by condensation of (IX) with cyanoguanidine (X) at 180 C.
【1】
Papoulis, A.T.; Queener, S.F.; Rosowsky, A.; Forsch, R.A.; Synthesis and antiparasitic and antitumor activity. J Med Chem 1999, 42, 6, 1007.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(II) |
23613 |
(3,4,5-trimethoxyphenyl)methanol
|
3840-31-1 |
C10H14O4 |
详情 | 详情
|
(III) |
14072 |
3,4,5-Trimethoxybenzyl chloride; 5-(Chloromethyl)-1,2,3-trimethoxybenzene; 4-(Chloromethyl)-2,6-dimethoxyphenyl methyl ether
|
3840-30-0 |
C10H13ClO3 |
详情 | 详情
|
(IV) |
23605 |
trimethylphosphine
|
594-09-2 |
C3H9P |
详情 | 详情
|
(V) |
23615 |
triphenyl(3,4,5-trimethoxybenzyl)phosphonium
|
|
C28H28O3P |
详情 |
详情
|
(VI) |
11377 |
1,4-Dioxaspiro[4.5]decan-8-one
|
4746-97-8 |
C8H12O3 |
详情 | 详情
|
(VII) |
23616 |
4-(1,4-dioxaspiro[4.5]dec-8-ylidenemethyl)-2,6-dimethoxyphenyl methyl ether; 8-(3,4,5-trimethoxybenzylidene)-1,4-dioxaspiro[4.5]decane
|
|
C18H24O5 |
详情 |
详情
|
(VIII) |
23617 |
4-(1,4-dioxaspiro[4.5]dec-8-ylmethyl)-2,6-dimethoxyphenyl methyl ether; 8-(3,4,5-trimethoxybenzyl)-1,4-dioxaspiro[4.5]decane
|
|
C18H26O5 |
详情 |
详情
|
(IX) |
23618 |
4-(3,4,5-trimethoxybenzyl)cyclohexanone
|
|
C16H22O4 |
详情 |
详情
|
(X) |
23611 |
N-cyanoguanidine
|
461-58-5 |
C2H4N4 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(VI) The acetylation of 2-(4-aminophenyl)acetic acid (I) with acetic anhydride, followed by nitration with nitric acid in acetic acid and treatment with HCl in ethanol gives 2-(4-amino-3-nitrophenyl)acetic acid ethyl ester (II), which is reduced at the nitro group, and cyclized with SOCl2 yielding the benzothiadiazole (III). The condensation of (III) with 3-fluoro-4-methoxyphenacyl bromide (IV) by means of potassium tert-butoxide affords the 4-oxobutyrate (V), which is condensed with 3,4,5-trimethoxybenzaldehyde (VI) by means of sodium methopxide in methanol to provide the the dihydrofuranone (VII). Finally, this compound is treated with NaOH in methanol to promote the opening of the lactone ring yielding the target compound.
【1】
Mederski, W.W.K.R.; Osswald, M.; Dorsch, D.; Anzali, S.; Christadler, M.; Schmitges, C.J.; Wilm, C.; Endothelin antagonists: Evaluation of 2,1, 3-benzothiadiazole as a methylendioxyphenyl bioisoster. Bioorg Med Chem Lett 1998, 8, 1, 17.
|
【2】
Mederski, W.W.K.R.; Dorsch, D.; Osswald, M.; Anzali, S.; Christadler, M.; Schmitges, C.J.; Schelling, P.; Wilm, C.; Fluck, M.; 3. Endothelin antagonists: Discovery of EMD 122946, a highly potent and orally active ETA selective antagonist. Bioorg Med Chem Lett 1998, 8, 13, 1771. |
【3】
Dorsch, D.; Osswald, M.; Mederski, W.; Wilm, C.; Schmitges, C.; Christadler, M.; Anzali, S. (Merck Patent GmbH); 2,1,3-Benzothia(oxa)diazole derivs. having an endothelin receptor antagonistic effect. DE 19607096; EP 0882030; WO 9730982 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21229 |
2-(4-Aminophenyl)acetic acid
|
5345-54-0 |
C8H9NO2 |
详情 | 详情
|
(II) |
26095 |
ethyl 2-(4-amino-3-nitrophenyl)acetate
|
|
C10H12N2O4 |
详情 |
详情
|
(III) |
26096 |
ethyl 2-(2,1,3-benzothiadiazol-5-yl)acetate
|
|
C10H10N2O2S |
详情 |
详情
|
(IV) |
26097 |
2-bromo-1-(3-fluoro-4-methoxyphenyl)-1-ethanone
|
|
C9H8BrFO2 |
详情 |
详情
|
(V) |
26098 |
ethyl 2-(2,1,3-benzothiadiazol-5-yl)-4-(3-fluoro-4-methoxyphenyl)-4-oxobutanoate
|
|
C19H17FN2O4S |
详情 |
详情
|
(VI) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(VII) |
26099 |
3-(2,1,3-benzothiadiazol-5-yl)-5-(3-fluoro-4-methoxyphenyl)-5-hydroxy-4-(3,4,5-trimethoxybenzyl)-2(5H)-furanone
|
|
C27H23FN2O7S |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(VI) Isovanillin (I) was protected as the silyl ether (II) and subsequently reduced to the benzyl alcohol (III). After conversion of (III) to bromide (IV), its reaction with triphenylphosphine gave phosphonium bromide (V). The ylide resulting from deprotonation of (V) with n-butyllithium was then condensed with 3,4,5-trimethoxybenzaldehyde (VI) to afford the required E-stilbene (VII) along with the corresponding Z-isomer, which were separated by column chromatography. Asymmetric Sharpless dihydroxylation of (VII) by means of AD mix-alpha provided the (1S,2S)-diol (VIII). Finally, desilylation of (VIII) using tetrabutylammonium fluoride afforded the target phenol.
【1】
Pettit, G.R.; Singh, S.B.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Schmidt, J.M.; Hogan, F.; Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6. J Med Chem 1995, 38, 10, 1666.
|
【2】
Pettit, G.R.; et al.; Antineoplastic agents. 410. Asymmetric hydroxylation of trans-combretastatin A-4. J Med Chem 1999, 42, 8, 1459.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18455 |
3-hydroxy-4-methoxybenzaldehyde; Isovanillin
|
621-59-0 |
C8H8O3 |
详情 | 详情
|
(II) |
26114 |
3-[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzaldehyde
|
|
C14H22O3Si |
详情 |
详情
|
(III) |
26115 |
(3-[[tert-butyl(dimethyl)silyl]oxy]-4-methoxyphenyl)methanol
|
|
C14H24O3Si |
详情 |
详情
|
(IV) |
26116 |
4-(bromomethyl)-2-[[tert-butyl(dimethyl)silyl]oxy]phenyl methyl ether; [5-(bromomethyl)-2-methoxyphenoxy](tert-butyl)dimethylsilane
|
|
C14H23BrO2Si |
详情 |
详情
|
(V) |
26117 |
(3-[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzyl)(triphenyl)phosphonium bromide
|
|
C32H38BrO2PSi |
详情 |
详情
|
(VI) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(VII) |
26118 |
tert-butyl[2-methoxy-5-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenoxy]dimethylsilane; tert-butyl(dimethyl)silyl 2-methoxy-5-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl ether
|
|
C24H34O5Si |
详情 |
详情
|
(VIII) |
26119 |
(1S,2S)-1-(3-[[tert-butyl(dimethyl)silyl]oxy]-4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-1,2-ethanediol
|
|
C24H36O7Si |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(XVIII) In a related procedure, iodination of acetophenone (XI) gave (XII). Subsequent alkylation of (XII) with dibromoethane afforded bromoethyl ether (XIII), which was converted to sulfide (XIV) by condensation with 4-chlorothiophenol (IX). Mannich reaction of (XIV) with paraformaldehyde and dimethylamine hydrochloride produced tertiary amine (XV), which was quaternized to (XVI) with MeI. Elimination in the resulting ammonium salt (XVI) produced vinyl ketone (XVII). Diketone (XIX) was then obtained by condensation with trimethoxybenzaldehyde (XVIII) in the presence of thiazolium salt (IV). Reduction of both ketone groups of (XIX) using NaBH4 yielded diol (XX), which was further cyclized with orthophosphoric acid in refluxing benzene to furnish a diastereomeric mixture of cis and trans diaryltetrahydrofurans (XXI). Iodine displacement in (XXI) with CuCN produced the corresponding diastereomeric mixture of cyanides, from which the target trans isomer was isolated by column chromatography.
【1】
Ram, B.; et al.; (±)-Trans-2-[3-methoxy-4-(4-chlorophenyl thioethoxy)-5-cyanophenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent PAF-receptor antagonist. Tetrahedron 1999, 55, 33, 10163. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10252 |
1,2-Dibromoethane; Ethylene dibromide
|
106-93-4 |
C2H4Br2 |
详情 | 详情
|
(IV) |
27942 |
3-benzyl-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium chloride
|
4568-71-2 |
C13H16ClNOS |
详情 | 详情
|
(IX) |
27947 |
4-chlorobenzenethiol
|
106-54-7 |
C6H5ClS |
详情 | 详情
|
(XI) |
22604 |
1-(4-hydroxy-3-methoxyphenyl)-1-ethanone;Acetovanillone;4’-hydroxy-3’-methoxyacetophenone;1-(4-hydroxy-3-methoxyphenyl)ethanone |
498-02-2 |
C9H10O3 |
详情 | 详情
|
(XII) |
27949 |
1-(4-hydroxy-3-iodo-5-methoxyphenyl)-1-ethanone
|
|
C9H9IO3 |
详情 |
详情
|
(XIII) |
27950 |
1-[4-(2-bromoethoxy)-3-iodo-5-methoxyphenyl]-1-ethanone
|
|
C11H12BrIO3 |
详情 |
详情
|
(XIV) |
27951 |
1-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-1-ethanone
|
|
C17H16ClIO3S |
详情 |
详情
|
(XV) |
27952 |
1-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-3-(dimethylamino)-1-propanone
|
|
C20H23ClINO3S |
详情 |
详情
|
(XVI) |
27953 |
3-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-N,N,N-trimethyl-3-oxo-1-propanaminium iodide
|
|
C21H26ClI2NO3S |
详情 |
详情
|
(XVII) |
27954 |
1-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-2-propen-1-one
|
|
C18H16ClIO3S |
详情 |
详情
|
(XVIII) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(XIX) |
27955 |
1-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,4-butanedione
|
|
C28H28ClIO7S |
详情 |
详情
|
(XX) |
27956 |
1-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-4-(3,4,5-trimethoxyphenyl)-1,4-butanediol
|
|
C28H32ClIO7S |
详情 |
详情
|
(XXI) |
27957 |
2-(4-[2-[(4-chlorophenyl)sulfanyl]ethoxy]-3-iodo-5-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran
|
|
C28H30ClIO6S |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(IV) Condensation of 3-methoxysalicylaldehyde (I) with cyanoacetamide (II) in the presence of piperidine gave rise to the carbamoyl iminochromene (III). Subsequent condensation of (III) with 3,4,5-trimethoxybenzaldehyde furnished the title compound.
【1】
Perry, P.J.; McGown, A.T.; Pavlidis, V.H.; Hadfield, J.A.; Synthesis and anticancer activities of 4-oxobenzopyrano[2,3-d]pyrimidines. Anti-Cancer Drugs 1999, 10, 6, 591.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12620 |
o-Vanillin; 2-Hydroxy-3-methoxybenzaldehyde
|
148-53-8 |
C8H8O3 |
详情 | 详情
|
(II) |
12122 |
Cyanoacetamide; 2-Cyanoacetamide
|
107-91-5 |
C3H4N2O |
详情 | 详情
|
(III) |
38139 |
2-imino-8-methoxy-2H-chromene-3-carboxamide
|
|
C11H10N2O3 |
详情 |
详情
|
(IV) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(I) The condensation between 3,4,5-trimethoxybenzaldehyde (I), 4-methylbenzenesulfinic acid (II) and formamide in the presence of camphorsulfonic acid gave tosyl-(3,4,5-trimethoxyphenyl)methylformamide (III), which was subsequently dehydrated to the isonitrile (IV) by treatment with POCl3 and Et3N. After conversion of 4-methoxy-3-nitrobenzaldehyde (V) to the corresponding imine with methylamine, its reaction with the tosylmethyl isonitrile (IV) gave rise to the diaryl imidazole (VI). The nitro group of (VI) was finally reduced to amine by using SnCl2 and HCl or ammonium formiate and Pd/C
【1】
Wang, L.; Woods, K.W.; Li, Q.; Barr, K.J.; McCroskey, R.M.; Hannick, S.M.; Gherke, L.; Credo, R.B.; Hui, Y.H.; Marsch, K.; Warner, R.; Lee, J.Y.; Zielinski-Mozng, N.; Frost, D.; Rosenberg, S.H.; Sham, H.L.; Potent, orally active heterocycle-based combretastatin A-4 analogues: Synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation. J Med Chem 2002, 45, 8, 1697. |
【2】
Wang, L.; Woods, K.W.; Li, Q.; Sham, H.L. (Abbott Laboratories Inc.); Imidazole antiproliferative agents. WO 0109103 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(II) |
25593 |
4-methylbenzenesulfinic acid
|
|
C7H8O2S |
详情 |
详情
|
(III) |
49071 |
[(4-methylphenyl)sulfonyl](3,4,5-trimethoxyphenyl)methylformamide
|
|
C18H21NO6S |
详情 |
详情
|
(IV) |
49072 |
2-[(4-methylphenyl)sulfonyl]-2-(3,4,5-trimethoxyphenyl)acetonitrile
|
|
C18H19NO5S |
详情 |
详情
|
(V) |
18225 |
4-METHOXY-3-NITROBENZALDEHYDE
|
31680-08-7 |
C8H7NO4 |
详情 | 详情
|
(VI) |
49073 |
2,3-dimethoxy-5-[5-(4-methoxy-3-nitrophenyl)-1-methyl-1H-imidazol-4-yl]phenyl methyl ether; 5-(4-methoxy-3-nitrophenyl)-1-methyl-4-(3,4,5-trimethoxyphenyl)-1H-imidazole
|
|
C20H21N3O6 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(I) Condensation of 3,4,5-trimethoxybenzaldehyde (I) with nitromethane in the presence of KOH produced the nitro alcohol (II), which was subsequently hydrogenated over Pd/C to afford amino alcohol (III). Acylation of (III) with 5-indolecarboxylic acid (IV) gave the corresponding amide (V). Oxazoline (VI) was then obtained by cyclization of (V) in the presence of Burgess reagent. Finally, N-methylation of the indole ring with MeI and KOH furnished the title compound.
【1】
Liu, G.; Jae, H.-S.; Szczepankiewicz, B.G.; et al.; New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models. J Med Chem 2001, 44, 25, 4416.
|
【2】
Woods, K.W.; Wang, L.; Kalvin, D.M.; Barr, K.J.; Li, Q.; Liu, G.; Gwaltney, S.L. II; Claiborne, A.K.; Jae, H.-S.; Sham, H.L. (Abbott Laboratories Inc.); Substd. oxazolines as antiproliferative agents. WO 0006556 .
|
【3】
Sham, H.L.; Jae, H.-S.; Li, Q.; Wang, L.; Woods, K.W.; Liu, G.; Barr, K.J.; Kalvin, D.M.; Gwaltney, S.L. II; Claiborne, A.K. (Abbott Laboratories Inc.); Oxazoline antiproliferative agents. US 6228868 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(II) |
48616 |
2-nitro-1-(3,4,5-trimethoxyphenyl)-1-ethanol
|
|
C11H15NO6 |
详情 |
详情
|
(III) |
48617 |
2-amino-1-(3,4,5-trimethoxyphenyl)-1-ethanol
|
|
C11H17NO4 |
详情 |
详情
|
(IV) |
48618 |
Indole-5-carboxylic acid
|
1670-81-1 |
C9H7NO2 |
详情 | 详情
|
(V) |
48619 |
N-[2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-1H-indole-5-carboxamide
|
|
C20H22N2O5 |
详情 |
详情
|
(VI) |
48620 |
5-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1,3-oxazol-2-yl]-1H-indole; 4-[2-(1H-indol-5-yl)-4,5-dihydro-1,3-oxazol-5-yl]-2,6-dimethoxyphenyl methyl ether
|
|
C20H20N2O4 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(I) By heating a mixture of 3,4,5-trimethoxybenzaldehyde (I), tetrahydro-1,4-oxazine (II) and precipitated sulfur, at 140 C
【1】
Banfi, S.; et al.; Research on 3,4,5-trimethoxy-benzamides. Note III. Synthesis and CNS depressant activity of new alkoxythiobenzamides. Chim Ther 1973, 4, 3, 462.
|
【2】
Castaner, J.; de Angelis, L.; Trithiozine. Drugs Fut 1976, 1, 8, 397.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(II) |
10388 |
Morpholine
|
110-91-8 |
C4H9NO |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(I) The condensation of 3,4,5-trimethoxybenzaldehyde (I) with 4-methylphenylsulfinic acid (II) and formamide by means of hot CSA gives the adduct (III), which is treated with POCl3 in DME to yield the isonitrile (IV). The reaction of benzaldehyde (V) with methylamine and AcOH in refluxing ethanol gives the enamine (VI), which is finally cyclized with isonitrile (IV) by means of K2CO3 in ethanol/DME to afford the target 1-methylimidazole.
【1】
Wang, L.; Woods, K.W.; Li, Q.; Barr, K.J.; McCroskey, R.M.; Hannick, S.M.; Gherke, L.; Credo, R.B.; Hui, Y.H.; Marsch, K.; Warner, R.; Lee, J.Y.; Zielinski-Mozng, N.; Frost, D.; Rosenberg, S.H.; Sham, H.L.; Potent, orally active heterocycle-based combretastatin A-4 analogues: Synthesis, structure-activity relationship, pharmacokinetics, and in vivo antitumor activity evaluation. J Med Chem 2002, 45, 8, 1697. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11136 |
3,4,5-Trimethoxybenzaldehyde
|
86-81-7 |
C10H12O4 |
详情 | 详情
|
(II) |
25593 |
4-methylbenzenesulfinic acid
|
|
C7H8O2S |
详情 |
详情
|
(III) |
49071 |
[(4-methylphenyl)sulfonyl](3,4,5-trimethoxyphenyl)methylformamide
|
|
C18H21NO6S |
详情 |
详情
|
(IV) |
49072 |
2-[(4-methylphenyl)sulfonyl]-2-(3,4,5-trimethoxyphenyl)acetonitrile
|
|
C18H19NO5S |
详情 |
详情
|
(V) |
63173 |
3,4-bis[(E)-2-(methylamino)ethenyl]benzaldehyde
|
|
C13H16N2O |
详情 |
详情
|
(VI) |
63174 |
(E)-N-methyl-2-{2-[(E)-2-(methylamino)ethenyl]-4-[(methylamino)methyl]phenyl}-1-ethenamine; N-{3,4-bis[(E)-2-(methylamino)ethenyl]benzyl}-N-methylamine
|
|
C14H21N3 |
详情 |
详情
|